FDA Approvals - B. Braun Anticipates Becoming First To Deliver FDA Approved 2g

B. Braun Anticipates Becoming First To Deliver FDA Approved 2g Cefazolin (Medical News Today)
B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, said today it anticipates U.S. Food and Drug Administration (FDA) approval for 2g Cefazolin for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX(R) Drug Delivery System. The FDA approval will make B.

Advanced Life Sciences Announces Outcome Of FDA's Anti-Infective Drugs Advisory Committee Review Of Restanza(TM) ... (Medical News Today)
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) announced that the FDA's Anti-Infective Drugs Advisory Committee voted in the majority that Restanza(TM) (cethromycin) demonstrated safety for the outpatient treatment of adults with mild-to-moderate community acquired pneumonia (CAP) (11 positive, 3 negative, 1 abstaining).

FDA Approvals - Agendia Supports Genentech's Citizen's Petition Urging FDA To Hold In-Vitro

Agendia Supports Genentech's Citizen's Petition Urging FDA To Hold In-Vitro Diagnostic Tests To One Set Of Scientific ... (Medical News Today)
Agendia, a world leader in molecular cancer diagnostics, announced its strong support of Genentech's Citizen's Petition. Filed on December 5, 2008, Docket No. FDA-2008-P-0638-0001/CP petitions that all in vitro diagnostic tests be held to one set of scientific and regulatory standards. In response, on May 28, 2009, Agendia formally submitted a letter of support to the U.S.

FDA Advisory Panel Recommends Approval Of The SEDASYS(R) System (Medical News Today)
Ethicon Endo-Surgery today announced that the Anesthesiology and Respiratory Therapy Devices Advisory Committee of the U.S.

FDA Approvals - MRSA SCREENING SYSTEM BEING DEVELOPED BY ONDINE BIOPHARMA CORPORATION (Wall

MRSA SCREENING SYSTEM BEING DEVELOPED BY ONDINE BIOPHARMA CORPORATION (Wall Street Transcript via Yahoo! Finance)
67 WALL STREET, New York - June 1, 2009 - The Wall Street Transcript has just published its Biotechnology Report report offering a timely review of the sector to serious investors and industry executives. This 107 page feature contains expert industry commentary through in-depth interviews. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online .

Oculus Innovative Sciences Receives FDA Clearance For Microcyn(R) Skin And Wound Gel (Medical News Today)
Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a healthcare company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Microcyn Skin and Wound Gel as both a prescription and over-the-counter formulation.

FDA Issues Advertising Guidelines On Product Risk Information (Medical News Today)
FDA on Tuesday posted on its Web site advertising guidelines for drugmakers and medical device manufacturers, offering suggestions on how to present risk information to health care professionals and consumers, the Wall Street Journal reports.


Notify me with the latest breaking FDA News
	Tell us where to send your notifications:

FDA News

FDA Approvals - B. Braun Anticipates Becoming First To Deliver FDA Approved 2g

FDA Approvals - Agendia Supports Genentech's Citizen's Petition Urging FDA To Hold In-Vitro

FDA Approvals - MRSA SCREENING SYSTEM BEING DEVELOPED BY ONDINE BIOPHARMA CORPORATION (Wall